Heparan sulfate expression in the neural crest is essential for mouse cardiogenesis

Matrix Biology

Volumn 35, Issue , 2014, Pages 253-265

  Pan, Yi ^a   Carbe, Christian ^b   Kupich, Sabine ^c   Pickhinke, Ute ^c   Ohlig, Stefanie ^c   Frye, Maike ^c   Seelige, Ruth ^c   Pallerla, Srinivas R ^c   Moon, Anne M ^d,e   Lawrence, Roger ^d   Esko, Jeffrey D ^d   Zhang, Xin ^b   Grobe, Kay ^c  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fibroblast growth factor; Heart development; Heparan sulfate; NDST1; Neural crest

Indexed keywords

FIBROBLAST GROWTH FACTOR 8; GROWTH FACTOR; HEPARAN SULFATE; MITOGEN ACTIVATED PROTEIN KINASE; N SULFOTRANSFERASE 1; SULFOTRANSFERASE; UNCLASSIFIED DRUG; FGF8 PROTEIN, MOUSE; HEPARITIN SULFOTRANSFERASE; PRIMER DNA;

APOPTOSIS; ARTICLE; BRANCHIAL ARCH; CELL FUNCTION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENZYME PHOSPHORYLATION; GENE TARGETING; HEART DEVELOPMENT; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM DEFECT; KNOCKOUT MOUSE; LOXP SITE; MOUSE; NEURAL CREST; NONHUMAN; PERSISTENT TRUNCUS ARTERIOSUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CONGENITAL HEART DISEASE; EMBRYOLOGY; GENETICS; HEART; HEART SEPTUM DEFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; ORGANOGENESIS; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCLAVIAN ARTERY;

MUS; VERTEBRATA;

ANIMALS; DNA PRIMERS; DOUBLE OUTLET RIGHT VENTRICLE; FIBROBLAST GROWTH FACTOR 8; HEART; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS, VENTRICULAR; HEPARITIN SULFATE; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; NEURAL CREST; ORGANOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBCLAVIAN ARTERY; SULFOTRANSFERASES; TRUNCUS ARTERIOSUS, PERSISTENT;

EID: 84901460208     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.10.013     Document Type: Article

References (77)

1. Abu-Issa R., Smyth G., Smoak I., Yamamura K., Meyers E.N. Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development 2002, 129:4613-4625.
2. Adhikari N., Basi D.L., Townsend D., Rusch M., Mariash A., Mullegama S., Watson A., Larson J., Tan S., Lerman B., Esko J.D., Selleck S.B., Hall J.L. Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling. J. Mol. Cell. Cardiol. 2010, 49:287-293.
3. Andelfinger G. Genetic factors in congenital heart malformation. Clin. Genet. 2008, 73:516-527.
4. Armstrong E.J., Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ. Res. 2004, 95:459-470.
5. Baasanjav S., Al-Gazali L., Hashiguchi T., Mizumoto S., Fischer B., Horn D., Seelow D., Ali B.R., Aziz S.A., Langer R., Saleh A.A., Becker C., Nurnberg G., Cantagrel V., Gleeson J.G., Gomez D., Michel J.B., Stricker S., Lindner T.H., Nurnberg P., Sugahara K., Mundlos S., Hoffmann K. Faulty initiation of proteoglycan synthesis causes cardiac and joint defects. Am. J. Hum. Genet. 2011, 89:15-27.
6. Brand T. Heart development: molecular insights into cardiac specification and early morphogenesis. Dev. Biol. 2003, 258:1-19.
7. Brault V., Moore R., Kutsch S., Ishibashi M., Rowitch D.H., McMahon A.P., Sommer L., Boussadia O., Kemler R. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 2001, 128:1253-1264.
8. Bullock S.L., Fletcher J.M., Beddington R.S.P., Wilson V.A. Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev. 1998, 12:1894-1906.
9. Cano-Gauci D.F., Song H.H., Yang H., McKerlie C., Choo B., Shi W., Pullano R., Piscione T.D., Grisaru S., Soon S., Sedlackova L., Tanswell A.K., Mak T.W., Yeger H., Lockwood G.A., Rosenblum N.D., Filmus J. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J. Cell Biol. 1999, 146:255-264.
10. Colvin J.S., Feldman B., Nadeau J.H., Goldfarb M., Ornitz D.M. Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene. Dev. Dyn. 1999, 216:72-88.
11. Costell M., Carmona R., Gustafsson E., Gonzalez-Iriarte M., Fassler R., Munoz-Chapuli R. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ. Res. 2002, 91:158-164.
12. Dell'Era P., Ronca R., Coco L., Nicoli S., Metra M., Presta M. Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. Circ. Res. 2003, 93:414-420.
13. Delot E.C., Bahamonde M.E., Zhao M., Lyons K.M. BMP signaling is required for septation of the outflow tract of the mammalian heart. Development 2003, 130:209-220.
14. Esko J.D., Lindahl U. Molecular diversity of heparan sulfate. J. Clin. Invest. 2001, 108:169-173.
15. Esko J.D., Selleck S.B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 2002, 71:435-471.
16. Fan G., Xiao L., Cheng L., Wang X., Sun B., Hu G. Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett. 2000, 467:7-11.
17. Filmus J., Capurro M., Rast J. Glypicans. Genome Biol. 2008, 9:224.
18. Forsberg E., Pejler G., Ringvall M., Lunderius C., Tomasini-Johansson B., Kusche-Gullberg M., Eriksson I., Ledin J., Hellman L., Kjellén L. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 1999, 400:773-776.
19. Frank D.U., Fotheringham L.K., Brewer J.A., Muglia L.J., Tristani-Firouzi M., Capecchi M.R., Moon A.M. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 2002, 129:4591-4603.
20. Fuster M.M., Wang L., Castagnola J., Sikora L., Reddi K., Lee P.H., Radek K.A., Schuksz M., Bishop J.R., Gallo R.L., Sriramarao P., Esko J.D. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J. Cell Biol. 2007, 177:539-549.
21. Gitler A.D., Brown C.B., Kochilas L., Li J., Epstein J.A. Neural crest migration and mouse models of congenital heart disease. Cold Spring Harb. Symp. Quant. Biol. 2002, 67:57-62.
22. Goddeeris M.M., Schwartz R., Klingensmith J., Meyers E.N. Independent requirements for Hedgehog signaling by both the anterior heart field and neural crest cells for outflow tract development. Development 2007, 134:1593-1604.
23. Grobe K., Esko J.D. Regulated translation of heparan sulfate N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes by structured 5'-untranslated regions and internal ribosome entry sites. J. Biol. Chem. 2002, 277:30699-30706.
24. Grobe K., Ledin J., Ringvall M., Holborn K., Forsberg E., Esko J.D., Kjellen L. Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase (NDST) isozymes. Biochim. Biophys. Acta 2002, 1573:209-215.
25. Grobe K., Inatani M., Pallerla S.R., Castagnola J., Yamaguchi Y., Esko J.D. Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development 2005, 132:3777-3786.
26. Hacker U., Nybakken K., Perrimon N. Heparan sulphate proteoglycans: the sweet side of development. Nat. Rev. Mol. Cell Biol. 2005, 6:530-541.
27. Holmborn K., Ledin J., Smeds E., Eriksson I., Kusche-Gullberg M., Kjellen L. Heparan sulfate synthesized by mouse embryonic stem cells deficient in NDST1 and NDST2 is 6-O-sulfated but contains no N-sulfate groups. J. Biol. Chem. 2004, 279:42355-42358.
28. Hotta Y., Sasaki S., Konishi M., Kinoshita H., Kuwahara K., Nakao K., Itoh N. Fgf16 is required for cardiomyocyte proliferation in the mouse embryonic heart. Dev. Dyn. 2008, 237:2947-2954.
29. Hu Z., Wang C., Xiao Y., Sheng N., Chen Y., Xu Y., Zhang L., Mo W., Jing N., Hu G. NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development. J. Cell Sci. 2009, 122:1145-1154.
30. Inatani M., Irie F., Plump A.S., Tessier-Lavigne M., Yamaguchi Y. Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. Science 2003, 302:1044-1046.
31. Ishihara M., Guo Y., Wei Z., Yang Z., Swiedler S.J., Orellana A., Hirschberg C.B. Regulation of biosynthesis of the basic fibroblast growth factor binding domains of heparan sulfate by heparan sulfate-N-deacetylase/N-sulfotransferase expression. J. Biol. Chem. 1993, 268:20091-20095.
32. Iwamoto R., Mine N., Kawaguchi T., Minami S., Saeki K., Mekada E. HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycans. Development 2010, 137:2205-2214.
33. Iwao K., Inatani M., Matsumoto Y., Ogata-Iwao M., Takihara Y., Irie F., Yamaguchi Y., Okinami S., Tanihara H. Heparan sulfate deficiency leads to Peters anomaly in mice by disturbing neural crest TGF-beta2 signaling. J. Clin. Invest. 2009, 119:1997-2008.
34. Kirby M.L., Waldo K.L. Neural crest and cardiovascular patterning. Circ. Res. 1995, 77:211-215.
35. Kuratani S.C., Kirby M.L. Migration and distribution of circumpharyngeal crest cells in the chick embryo. Formation of the circumpharyngeal ridge and E/C8+ crest cells in the vertebrate head region. Anat. Rec. 1992, 234:263-280.
36. Lanner F., Lee K.L., Sohl M., Holmborn K., Yang H., Wilbertz J., Poellinger L., Rossant J., Farnebo F. Heparan sulfation-dependent fibroblast growth factor signaling maintains embryonic stem cells primed for differentiation in a heterogeneous state. Stem Cells 2010, 28:191-200.
37. Lavine K.J., Yu K., White A.C., Zhang X., Smith C., Partanen J., Ornitz D.M. Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev. Cell 2005, 8:85-95.
38. Lawrence R., Olson S.K., Steele R.E., Wang L., Warrior R., Cummings R.D., Esko J.D. Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling. J. Biol. Chem. 2008, 283:33674-33684.
39. Li J.P., Gong F., Hagner-McWhirter A., Forsberg E., Abrink M., Kisilevsky R., Zhang X., Lindahl U. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking l-iduronic acid and in neonatal lethality. J. Biol. Chem. 2003, 278:28363-28366.
40. Lin A.E., Neri G., Hughes-Benzie R., Weksberg R. Cardiac anomalies in the Simpson-Golabi-Behmel syndrome. Am. J. Med. Genet. 1999, 83:378-381.
41. Lin X., Buff E.M., Perrimon N., Michelson A.M. Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 1999, 126:3715-3723.
42. Lin L., Bu L., Cai C.L., Zhang X., Evans S. Isl1 is upstream of sonic hedgehog in a pathway required for cardiac morphogenesis. Dev. Biol. 2006, 296:756-763.
43. Lindahl U., Kusche-Gullberg M., Kjellén L. Regulated diversity of heparan sulfate. J. Biol. Chem. 1998, 273:24979-24982.
44. Lindsay E.A. Chromosomal microdeletions: dissecting del22q11 syndrome. Nat. Rev. Genet. 2001, 2:858-868.
45. Liu W., Selever J., Wang D., Lu M.F., Moses K.A., Schwartz R.J., Martin J.F. Bmp4 signaling is required for outflow-tract septation and branchial-arch artery remodeling. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:4489-4494.
46. Macatee T.L., Hammond B.P., Arenkiel B.R., Francis L., Frank D.U., Moon A.M. Ablation of specific expression domains reveals discrete functions of ectoderm- and endoderm-derived FGF8 during cardiovascular and pharyngeal development. Development 2003, 130:6361-6374.
47. Maschhoff K.L., Baldwin H.S. Molecular determinants of neural crest migration. Am. J. Med. Genet. 2000, 97:280-288.
48. McLaughlin D., Karlsson F., Tian N., Pratt T., Bullock S.L., Wilson V.A., Price D.J., Mason J.O. Specific modification of heparan sulphate is required for normal cerebral cortical development. Mech. Dev. 2003, 120:1481-1488.
49. Meyers E.N., Lewandoski M., Martin G.R. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 1998, 18:136-141.
50. Miller D.L., Ortega S., Bashayan O., Basch R., Basilico C. Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol. Cell. Biol. 2000, 20:2260-2268.
51. Moon A.M., Capecchi M.R. Fgf8 is required for outgrowth and patterning of the limbs. Nat. Genet. 2000, 26:455-459.
52. Moon A.M., Guris D.L., Seo J.H., Li L., Hammond J., Talbot A., Imamoto A. Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Dev. Cell 2006, 10:71-80.
53. Ng A., Wong M., Viviano B., Erlich J.M., Alba G., Pflederer C., Jay P.Y., Saunders S. Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development. Dev. Biol. 2009, 335:208-215.
54. Ostrovsky O., Berman B., Gallagher J., Mulloy B., Fernig D.G., Delehedde M., Ron D. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J. Biol. Chem. 2002, 277:2444-2453.
55. Pallerla S.R., Pan Y., Zhang X., Esko J.D., Grobe K. Heparan sulfate Ndst1 gene function variably regulates multiple signaling pathways during mouse development. Dev. Dyn. 2007, 236:556-563.
56. Pan Y., Woodbury A., Esko J.D., Grobe K., Zhang X. Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. Development 2006, 133:4933-4944.
57. Pan Y., Carbe C., Powers A., Zhang E.E., Esko J.D., Grobe K., Feng G.S., Zhang X. Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction. Development 2008, 135:301-310.
58. Park E.J., Ogden L.A., Talbot A., Evans S., Cai C.L., Black B.L., Frank D.U., Moon A.M. Required, tissue-specific roles for Fgf8 in outflow tract formation and remodeling. Development 2006, 133:2419-2433.
59. Park E.J., Watanabe Y., Smyth G., Miyagawa-Tomita S., Meyers E., Klingensmith J., Camenisch T., Buckingham M., Moon A.M. An FGF autocrine loop initiated in second heart field mesoderm regulates morphogenesis at the arterial pole of the heart. Development 2008, 135:3599-3610.
60. Pennisi D.J., Ballard V.L., Mikawa T. Epicardium is required for the full rate of myocyte proliferation and levels of expression of myocyte mitogenic factors FGF2 and its receptor, FGFR-1, but not for transmural myocardial patterning in the embryonic chick heart. Dev. Dyn. 2003, 228:161-172.
61. Porras D., Brown C.B. Temporal-spatial ablation of neural crest in the mouse results in cardiovascular defects. Dev. Dyn. 2008, 237:153-162.
62. Qu X., Hertzler K., Pan Y., Grobe K., Robinson M.L., Zhang X. Genetic epistasis between heparan sulfate and FGF-Ras signaling controls lens development. Dev. Biol. 2011, 355:12-20.
63. Qu X., Pan Y., Carbe C., Powers A., Grobe K., Zhang X. Glycosaminoglycan-dependent restriction of FGF diffusion is necessary for lacrimal gland development. Development 2012, 139:2730-2739.
64. Rapraeger A.C., Krufka A., Olwin B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991, 252:1705-1708.
65. Ringvall M., Ledin J., Holmborn K., Van Kuppevelt T., Ellin F., Eriksson I., Olofsson A.M., Kjellén L., Forsberg E. Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J. Biol. Chem. 2000, 275:25926-25930.
66. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., Sariola H., Friedman R., Boivin G.P., Cardell E.L., Doetschman T. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 1997, 124:2659-2670.
67. Schneider R.A., Hu D., Rubenstein J.L., Maden M., Helms J.A. Local retinoid signaling coordinates forebrain and facial morphogenesis by maintaining FGF8 and SHH. Development 2001, 128:2755-2767.
68. Schultz J.E., Witt S.A., Nieman M.L., Reiser P.J., Engle S.J., Zhou M., Pawlowski S.A., Lorenz J.N., Kimball T.R., Doetschman T. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J. Clin. Invest. 1999, 104:709-719.
69. Song L., Li Y., Wang K., Zhou C.J. Cardiac neural crest and outflow tract defects in Lrp6 mutant mice. Dev. Dyn. 2010, 239:200-210.
70. Sun X., Meyers E.N., Lewandoski M., Martin G.R. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev. 1999, 13:1834-1846.
71. van den Born J., Salmivirta K., Henttinen T., Ostman N., Ishimaru T., Miyaura S., Yoshida K., Salmivirta M. Novel heparan sulfate structures revealed by monoclonal antibodies. J. Biol. Chem. 2005, 280:20516-20523.
72. Washington Smoak I., Byrd N.A., Abu-Issa R., Goddeeris M.M., Anderson R., Morris J., Yamamura K., Klingensmith J., Meyers E.N. Sonic hedgehog is required for cardiac outflow tract and neural crest cell development. Dev. Biol. 2005, 283:357-372.
73. Watanabe Y., Miyagawa-Tomita S., Vincent S.D., Kelly R.G., Moon A.M., Buckingham M.E. Role of mesodermal FGF8 and FGF10 overlaps in the development of the arterial pole of the heart and pharyngeal arch arteries. Circ. Res. 2010, 106:495-503.
74. Yayon A., Klagsbrun M., Esko J.D., Leder P., Ornitz D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991, 64:841-848.
75. Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M., Ornitz D.M. Receptor specificity of the fibroblast growth factor family the complete mammalian FGF family. J. Biol. Chem. 2006, 281:15694-15700.
76. Zhang J., Lin Y., Zhang Y., Lan Y., Lin C., Moon A.M., Schwartz R.J., Martin J.F., Wang F. Frs2alpha-deficiency in cardiac progenitors disrupts a subset of FGF signals required for outflow tract morphogenesis. Development 2008, 135:3611-3622.
77. Zhou M., Sutliff R.L., Paul R.J., Lorenz J.N., Hoying J.B., Haudenschild C.C., Yin M., Coffin J.D., Kong L., Kranias E.G., Luo W., Boivin G.P., Duffy J.J., Pawlowski S.A., Doetschman T. Fibroblast growth factor 2 control of vascular tone. Nat. Med. 1998, 4:201-207.